SCHEMBL22353100

SCHEMBL22353100

COc1ccc(Cn2cc(C(F)(F)F)cn2)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 2/20 0.52
HSP90AB1 P08238 2/20 0.52
NPBWR1 P48145 2/20 0.52
L3MBTL1 Q9Y468 1/20 0.48
GRIN1 Q05586 1/20 0.46
GRIN2B Q13224 1/20 0.46
TEK Q02763 2/20 0.46
KDR P35968 1/20 0.46
MAPT P10636 2/20 0.46
MEN1 O00255 2/20 0.45
KMT2A Q03164 2/20 0.45
NPC1 O15118 1/20 0.45
RAB9A P51151 1/20 0.45
EPHB4 P54760 1/20 0.43
GPR55 Q9Y2T6 1/20 0.43
KDM4E B2RXH2 1/20 0.42
ALDH1A1 P00352 1/20 0.42
ALOX15 P16050 1/20 0.42
CMA1 P23946 1/20 0.42
KLKB1 P03952 3/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22951371 0.88 HSP90AA1 (0.58) HSP90AA1HSP90AB1NPBWR1L3MBTL1MAPT
SCHEMBL26622753 0.85 L3MBTL1 (0.49) HSP90AA1HSP90AB1NPBWR1L3MBTL1MAPT
SCHEMBL27901467 0.82 L3MBTL1 (0.53) HSP90AA1HSP90AB1NPBWR1L3MBTL1MAPT
SCHEMBL24608608 0.82 HSP90AA1 (0.46) HSP90AA1HSP90AB1NPBWR1L3MBTL1MAPT
SCHEMBL17385332 0.81 MAPT (0.50) HSP90AA1HSP90AB1NPBWR1L3MBTL1MAPT
SCHEMBL13723406 0.80 L3MBTL1 (0.68) HSP90AA1HSP90AB1NPBWR1L3MBTL1MAPT
SCHEMBL13254189 0.80 MEN1 (0.55) HSP90AA1HSP90AB1NPBWR1L3MBTL1MAPT
SCHEMBL3977038 0.79 L3MBTL1 (0.44) HSP90AA1HSP90AB1NPBWR1L3MBTL1MAPT
SCHEMBL16093363 0.78 L3MBTL1 (0.50) HSP90AA1HSP90AB1NPBWR1L3MBTL1MAPT
SCHEMBL2054328 0.78 L3MBTL1 (0.50) HSP90AA1HSP90AB1NPBWR1L3MBTL1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11161835-B2 Compounds and their use for reducing uric acid levels ACQUIST LLC (US) 2021-11-02 US disclosed
US-20200339545-A1 Compounds And Their Use For Reducing Uric Acid Levels ACQUIST LLC (US) 2020-10-29 US disclosed
US-10752613-B2 Compounds and their use for reducing uric acid levels ACQUIST LLC (US) 2020-08-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200339545-A1 Compounds And Their Use For Reducing Uric Acid Levels XDH, OAT, PON1 HSP90AA1 3690/4885HSP90AB1 4070/4885NPBWR1 3149/4885
US-11161835-B2 Compounds and their use for reducing uric acid levels XDH, OAT, PON1 HSP90AA1 3690/4885HSP90AB1 4070/4885NPBWR1 3149/4885
US-10752613-B2 Compounds and their use for reducing uric acid levels XDH, OAT, PON1 HSP90AA1 3690/4885HSP90AB1 4070/4885NPBWR1 3149/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.